Skip to main content
OpenTrials

Clinical trial condition

Stage IIIB Cutaneous Melanoma AJCC v7

Explore clinical trials studying Stage IIIB Cutaneous Melanoma AJCC v7. Study availability and eligibility vary by location and protocol.

20 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage IIIB Cutaneous Melanoma AJCC v7 trial results

Active, not recruiting

Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

NCT01274338

Conditions
Melanoma, Melanoma of Unknown Primary, Neoplasms, +14 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Alaska Regional Hospital Anchorage, Alaska, United States
View all 937 locations
View Trial Details
Active, not recruiting

Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

NCT01134614

Conditions
Advanced Melanoma, Melanoma, Metastatic Melanoma, +18 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • VA Palo Alto Health Care System Palo Alto, California, United States
  • Eisenhower Medical Center Rancho Mirage, California, United States
View all 257 locations
View Trial Details
Active, not recruiting

Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma

NCT02965716

Conditions
Advanced Melanoma, Melanoma, Neoplasms, +17 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 20 locations
View Trial Details
Completed

Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

NCT01708941

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +14 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Rocky Mountain Cancer Centers-Aurora Aurora, Colorado, United States
  • The Medical Center of Aurora Aurora, Colorado, United States
  • Boulder Community Foothills Hospital Boulder, Colorado, United States
View all 276 locations
View Trial Details

Related conditions